MMP-2 1306 C/T promoter polymorphism and smoking: A possible role as risk factors in lung cancer

被引：0
|
作者：
Daniele, A. [1 ]
Rosa, D. [1 ]
Lapadula, V. [1 ]
Abbate, I. [1 ]
Galetta, D. [1 ]
Montagna, E. S. [1 ]
Catino, A. [1 ]
机构：
[1] Ist Tumori Giovanni Paolo II, Oncol Med, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
D O I：
10.1016/S1556-0864(18)30294-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14P
引用
下载
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [31] Associations of MMP-2-1306 C/T and MMP-9-1562 C/T polymorphisms with breast cancer risk among different populations: a meta-analysis
    Han, Meng
    Yang, Qingfeng
    Feng, Kai
    Li, Rongping
    Ren, Jia
    Wei, Liguang
    GENES & GENOMICS, 2017, 39 (03) : 331 - 340
  • [32] Cigarette Smoking and Polymorphism of the Paraoxonase 1 Gene as Risk factors for Lung Cancer
    Lee, Chul-Ho
    Lee, Kye Young
    Hong, Yun-Chul
    Choe, Kang-Hyeon
    Kim, Yong-Dae
    Kang, Jong-Won
    Kim, Heon
    Hong, Jang Soo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 58 (05) : 490 - 497
  • [33] Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects
    Zhang, Kaiping
    Chen, Xianguo
    Zhou, Jun
    Yang, Cheng
    Zhang, Meng
    Chao, Min
    Zhang, Li
    Liang, Chaozhao
    ONCOTARGET, 2017, 8 (27) : 45020 - 45029
  • [34] Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population
    Chaudhary, Ajay Kumar
    Pandya, Shruti
    Mehrotra, Ravi
    Singh, Mangal
    Singh, Mamta
    BIOMARKERS, 2011, 16 (07) : 577 - 586
  • [35] The Association of MMP-9 Enzyme Activity, MMP-9 C1562T Polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 Gene Expression in Lung Cancer
    Bayramoglu, Aysegul
    Gunes, Hasan Veysi
    Metintas, Muzaffer
    Degirmenci, Irfan
    Mutlu, Fezan
    Alatas, Fusun
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (05) : 671 - 678
  • [36] Elevated expression of MMP-2 and TIMP-2 cooperatively correlates with risk of lung cancer
    Cao, Chao
    Xu, Ning
    Zheng, Xiaoxia
    Zhang, Wenxue
    Lai, Tianwen
    Deng, Zaichun
    Huang, Xiaoping
    ONCOTARGET, 2017, 8 (46) : 80560 - 80567
  • [37] Elevated Expression Of Mmp-2 And Timp-2 Cooperatively Correlates With Risk Of Lung Cancer
    Cao, C.
    Zhang, W.
    Huang, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [38] A genetic polymorphism in prostaglandin synthase 2 (8473, T → C) and the risk of lung cancer
    Sorensen, M
    Autrup, H
    Tjonneland, A
    Overvad, K
    Raaschou-Nielsen, O
    CANCER LETTERS, 2005, 226 (01) : 49 - 54
  • [39] A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A,-1306C/T,-790T/G and-735C/T) is associated with coronary triple-vessel disease
    Vasku, A
    Goldbergová, M
    Hollá, LI
    Sisková, L
    Groch, L
    Beránek, M
    Tschöplová, S
    Znojil, V
    Vácha, J
    MATRIX BIOLOGY, 2004, 22 (07) : 585 - 591
  • [40] A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking
    Hu, ZB
    Ma, HX
    Lu, DR
    Zhou, JN
    Chen, YJ
    Xu, L
    Zhu, JF
    Huo, X
    Qian, J
    Wei, QY
    Shen, HB
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 457 - 463
12345